The annexins: spatial and temporal coordination of signaling events during cellular stress by Monastyrskaya, Katia et al.
REVIEW
The annexins: spatial and temporal coordination of signaling
events during cellular stress
Katia Monastyrskaya Æ Eduard B. Babiychuk Æ
Annette Draeger
Received: 5 January 2009 / Revised: 9 February 2009 / Accepted: 27 March 2009 / Published online: 21 April 2009
 Birkha¨user Verlag, Basel/Switzerland 2009
Abstract Annexins are a family of structurally related,
Ca2?-sensitive proteins that bind to negatively charged
phospholipids and establish specific interactions with other
lipids and lipid microdomains. They are present in all
eukaryotic cells and share a common folding motif, the
‘‘annexin core’’, which incorporates Ca2?- and membrane-
binding sites. Annexins participate in a variety of intra-
cellular processes, ranging from the regulation of
membrane dynamics to cell migration, proliferation, and
apoptosis. Here we focus on the role of annexins in cellular
signaling during stress. A chronic stress response triggers
the activation of different intracellular pathways, resulting
in profound changes in Ca2? and pH homeostasis and
the production of lipid second messengers. We review the
latest data on how these changes are sensed by the
annexins, which have the ability to simultaneously interact
with specific lipid and protein moieties at the plasma
membrane, contributing to stress adaptation via regulation
of various signaling pathways.
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Introduction
The plasma membrane is not just a barrier separating the
cell from its environment, its proteins and lipids also
coordinate and route the incoming and outgoing signals.
The amplification and redistribution of signals are in many
cases accomplished by a highly regulated intracellular
release of Ca2? or a controlled entry of Ca2? through the
plasma membrane. Chronic stress conditions are often
accompanied by extracellular acidification, oxidative
stress, cytokine-induced cell proliferation, and gene muta-
tions [1]. There is a significant interplay between
intracellular Ca2? and pH homeostasis: changes in pHi are
often accompanied by an alteration of [Ca2?]i, intracellular
acidification correlates with a marked increase in [Ca2?]i
due to the altered activity of calcium-entry channels,
release from intracellular stores and its decreased affinity
for Ca2?-binding proteins [2, 3]. On the other hand, Ca2?
influx through store-operated channels mediates intracel-
lular alkalinization [4], and the proteins involved in
maintaining the pH homeostasis are regulated by
Ca2?-binding proteins, which are activated by many
stimuli (Ras, PKC) sensitive to [Ca2?]i [5]. Extracellular
stress factors can incite contraction, division, secretion,
cytokine-induced cell proliferation, gene mutations, or
apoptosis. The basic stress signal can be as variable as the
cellular response and is dependent on the cell type and the
extent of the stimulus. Members of the annexin protein
family are characterized by their distinct Ca2?- and
phospholipid-binding properties and have the ability to
converge at the plasma membrane during stress. They act
as intracellular sensors discriminating the incoming signals
and thus may provide each cell type with individuality in
its reaction to the changing environment.
Ca21-binding proteins: the annexin family
There are several classes of Ca2?-binding proteins ranging
from Ca2?-gated channels within the membranes, proteins
serving as Ca2? buffers, and proteins that change their
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functions in response to Ca2?-binding, thus directly par-
ticipating in the signaling [6]. Based on the structure of
their Ca2?-binding sites, the Ca2?-binding proteins can be
classified as EF-hand proteins, C2-domain proteins and
annexin, or type-II, Ca2?-binding-site proteins. Annexins
are a family of structurally related, Ca2?-sensitive pro-
teins that bind to negatively charged phospholipids [7]
and establish specific interactions with other lipids and
lipid microdomains [8, 9]. Annexins were initially dis-
covered as proteins, mediating the Ca2?-dependent
aggregation of chromaffin granules [10]. Synexin, now
known as human annexin A7, was the first member of the
family whose Ca2?- and membrane-binding properties
were extensively studied [11]. Its discovery was followed
by annexins A1 and A2 (then called lipocortin and calp-
actin), identified as substrates of Src and EGF protein
kinases [12, 13]. Already the early studies identified a
complex between annexin A2 and a member of EF-hand
Ca2?-binding S100 protein p11 (S100A10) [14]. The
interaction of annexins with S100 proteins is a feature
shared by most members of the family [15]. The 12
vertebrate annexins form the A family (annexins A1-A13,
A12 left unassigned). The other annexins are currently
classified into families B (invertebrates), C (fungi and
unicellular eukaryotes), D (plants), and E (protists) [16].
The structure and diverse functions of annexins have been
extensively reviewed [7, 17–19], so here we will only
give a brief overview of the important features of these
molecules, before concentrating specifically on their role
in cell signaling events occurring at the plasma membrane
during intracellular stress.
Molecular structure of annexins
All annexins possess a common folding motif, the
C-terminal ‘‘core domain’’ [16]. The core domain incor-
porates functional sequences that are common for all
members of the annexin protein family including Ca2?-
binding sites and sites responsible for the interactions with
negatively charged phospholipids. In contrast, the NH2-
terminal domains are variable and are thought to confer
specific properties of each individual annexin.
Crystal structures of annexins have been determined for
the core domains and proteins with short NH2-termini
[20–22]. The Ca2?-binding sites of all annexins are located
within the conserved core domain, comprising four (eight
in the case of annexin A6) annexin repeats, each 70 amino
acids long, forming five a-helices connected by short loops.
The annexin core has the shape of a slightly curved disc,
with Ca2?- and lipid-binding sites located at the convex
face of the molecule. Ca2?, which is essential for the
membrane interaction of most annexins, simultaneously
coordinates carbonyl and carboxyl groups of the protein
and phosphoryl groups at the glycerol backbone of mem-
brane phospholipids [23]. Ca2? binding leads to the
conformational changes in the core domain, particularly in
repeat III [8, 20, 24].
The variability of the NH2-termini is thought to influ-
ence the specificity of the Ca2?- and phospholipid-binding
ability of the annexins. The NH2-terminal domains of
annexins harbor sites for post-translational modification as
well as for the interaction with other proteins [17]. The
EF-hand proteins of the S100 family form the largest group
of annexin-associated proteins, which are bound to the
NH2-termini of annexins. The interaction of different
annexins with S100 proteins has been the subject of two
recent reviews [15, 25]. Here we discuss the annexin
A2-S100A10 complex because its formation significantly
alters the properties of annexin A2 and is implicated in
many regulatory functions. Annexin A2 exists as a mono-
mer (p36) or a heterotetramer (p90), in which two annexin
molecules are associated with a dimer of S100A10 (p11).
Annexin A2 forms a Ca2?-independent complex
with S100A10, whereas the interaction of other annexins
with S100 proteins, e.g. the association of annexin A1 with
S100A11, requires Ca2?. Mutagenesis analysis showed that
the NH2-terminal domain of annexin A2 regulates
Ca2?-dependent membrane aggregation [26]. Due to the
formation of a heterotetrameric complex with S100A10,
annexin A2 gains the ability to aggregate membranes at
micromolar Ca2? concentrations [7].
The effects of the NH2-termini on Ca
2? binding are
modulated not only via their modifications such as phos-
phorylation or binding to other proteins, but also directly
following the conformational changes in this region of the
molecule [27]. The role of the NH2-terminus in the mod-
ulation of Ca2? sensitivity of lipid binding is apparent in
the case of annexin A1. Truncated annexin A1 has a typical
core structure [28], resembling annexin A5 and the core
domain of annexin A2. The NH2-terminus of the full-
length protein inserts into the core, replacing and
unwinding one of the helices. Upon Ca2? and membrane
binding, the NH2-terminus is expelled from the molecule
and becomes available for other interactions, and the core
Ca2? binding site is restored [29]. It is possible that in the
absence of Ca2? ions, annexin A1 might be in its inactive
form, and only after Ca2? and/or phospholipid-binding,
which promote an overall conformational change, annexin
A1 assumes a structure allowing it to aggregate
membranes.
Some annexins, including annexin A1, A2, A4, and A7
can promote membrane interaction in vitro, which has led
to the hypothesis of their involvement in endocytosis and
exocytosis. The mechanism of simultaneous interactions
with two membranes could be either via protein-protein
interactions, such as the one described for the A2-S100A10
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heterotetramer [30], or directly via two independent
membrane-binding sites within one annexin molecule
[31, 32]. Alternatively, since annexin A1 binds S100A11
protein in a Ca2?-dependent manner, the complex might
form a symmetrical membrane-binding unit, linking two
membranes [33]. Annexin A6 contains two cores, which
are flexible and can orient themselves, allowing the mol-
ecule to interact with one or two membranes [34].
Expression and distribution of annexins
The expression of multiple annexins within each cell and
the high similarity of the annexin molecular structure
indicate the importance of these proteins. Indeed, although
the distribution of annexins varies in human tissues and
organs, these proteins are highly abundant in smooth
muscle (annexins A1, A2, A4, A6) [8, 35], cardiomyocytes
(annexins A4, A5, A6, and A7) [36], and endothelial cells
(annexins A1, A2, A5, and A6) [37]. On the other hand,
expression of some annexins is restricted to specific tissue
types: annexin A3 to neutrophils and placenta, annexin A8
to skin, annexin A9 to tongue, and annexin A13 to small
intestine [38–40].
When cellular functions deteriorate, frequent changes in
the expression levels of annexins are observed [41].
Notably, most forms of human cancer are associated with
significant alterations in the expression pattern of annexins,
consistent with the role of these proteins in linking plasma
membrane to cytoskeleton, maintenance of intracellular
contacts, and endocytosis [42]. Annexins A1, A2, A4, and
A6 are down-regulated in prostate cancer [43], and annexin
A7 is a candidate tumor suppressor gene in prostate cancer,
inhibiting prostate cell migration [44]. In acontractile
bladders, concomitant with degenerative changes in
smooth muscle cells, the expression of annexin A6 is
reduced, which might have a bearing on the fine-tuning of
the contractile apparatus [45].
At low [Ca2?]i, annexins are diffusely distributed
throughout the cytosol. After stimulation and [Ca2?]i ele-
vation, they translocate to cellular membranes [35]
(Fig. 1). Annexin A2 is involved in intracellular vesicle
movement [46] and is associated with endosomal function.
Endosomal localization has also been reported for annexins
A1 and A6 [47, 48]. Annexin A5 has previously been
associated with late endosomes [49, 50]. Annexins A5 and
A6 have been associated with the Golgi apparatus, vacuolar
membranes, and the endoplasmic reticulum [50, 51]. Sev-
eral annexins (among them annexins A1 and A5) have been
localized to the nucleus [52]. Hence, the intracellular
translocation of annexins represents an important mecha-
nism for targeting specific substrates and for the control of
individual protein or lipid function.
Annexins regulate plasma membrane architecture
Annexins interact with specific lipids
Annexins are defined through their ability to bind nega-
tively charged phospholipids, however, there are
differences in binding to phospholipids with particular
headgroups [phosphatidylserine (PS), phosphatidylinositol
(PI), phosphatidic acid (PA)] [53]. Negatively charged
phospholipids best promote binding of most annexins to
Fig. 1 Ca2?-dependent localization of annexins A4 and A6 in
smooth muscle cells. Fluorescent micrographs of transverse ultra-
thin cryosections through human myometrium. a Double labeling
with a monoclonal antibody against annexin A6 (anx6: green) and
nuclear dye Hoechst (Hoechst: blue). Contracted cells are outlined by
annexin A6 translocation to the plasma membrane, whereas in relaxed
cells, this protein shows a diffuse cytoplasmic distribution. b Double
labeling with a polyclonal antibody against annexin A6 (anx6: green)
and a monoclonal one against annexin A4 (anx4: red). Note the
cytoplasmic localization of annexin A4 in contrast to plasma
membrane-associated annexin A6 (asterisks), indicating that in some
cells, [Ca2?]i is above annexin A6’s, but below annexin A4’s
sensitivity for membrane translocation
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phosphatidylcholine (PC)-containing membranes [54]. A
comparison of 11 different types of lipids revealed that
other factors such as the type of ion contributing the
charge and head-group size were also important. Mixing
phosphatidylserine and phosphatidylethanolamine or
phosphatidylserine and phosphatidylinositol in the same
PC vesicle synergistically enhanced annexin A4-mem-
brane binding [54].
Lipid A is an active component of bacterial endotoxin in
the bacterial envelope [55]. Annexins A1 and A2 were
found to bind to this lipid, and the binding might have a
role in suppressing the cellular and systemic responses to
endotoxin by inhibiting its interactions with cellular
receptors or accessory binding proteins [55].
Phosphatidylinositol 4,5-bisphosphate (PtdIns4,5P2 or
PIP2) is a major phosphoinositide of the plasma membrane
that comprises about 1% of the plasma membrane phos-
pholipids [56]. PtdIns4,5P2 is the precursor of the second
messengers inositol 1,4,5-triphosphate (IP3) and diacyl-
glycerol (DAG) [57] and plays a role in regulation of actin
cytoskeleton [58]. PtdIns4,5P2 is a binding partner of
annexin A2 at the sites of its membrane-dependent inter-
action with actin [59, 60]. Direct binding of annexin A2 to
PtdIns4,5P2 in actin-rearrangement sites was demonstrated
by Rescher et al. [60], who observed the accumulation of
annexin A2 at the attachment sites of enteropathogenic
E. coli, together with a concentration of cholesterol and an
aggregation of GPI-anchored proteins [60, 61]. Simulta-
neously, in liposome sedimentation assays, Hayes et al.
[59] demonstrated that recombinant annexin A2 bound to
PtdIns4,5P2 but not to other poly- and mono-phosphoino-
sitides in the presence and absence of Ca2?. Since
PtdIns4,5P2 is a precursor for many lipid second messengers
(IP3 and DAG) and involved in vesicular trafficking and
cell motility, these results support the role of annexin A2 in
the regulation of membrane-cytoskeleton dynamics in
vesicle trafficking and indicate a possibility of its
involvement in other cell signaling events [59].
Cholesterol is an important membrane constituent,
therefore the association of annexins with cholesterol and
cholesterol-rich membranes was extensively investigated.
Annexin A2 was shown to interact with cholesterol and its
distribution was modulated by the subcellular distribution
of cholesterol in cells from patients with the cholesterol-
storage disorder Niemann-Pick C [47]. The authors con-
clude that annexin A2 forms cholesterol-containing
platforms on early endosomal membranes and that these
platforms regulate the onset of the degradation pathway in
animal cells [47]. Annexin A2 was shown to interact with
endosomal membranes independent of Ca2? [62], and this
binding was demonstrated to be mediated by cholesterol
[9, 63]. Annexin A2 is tightly membrane-associated in a
cholesterol-dependent manner and interacts physically with
elements of the cortical actin cytoskeleton. Taking into
account these observations, the authors proposed that this
protein serves as an interface between membranes con-
taining high amounts of cholesterol and the actin
cytoskeleton. In addition, annexin A2 is thought to play a
role in cholesterol uptake: it associates with caveolin-1 in
cultured cells during cholesterol uptake [64] and forms a
tight complex with caveolin in zebrafish intestinal epithe-
lium [65]. Annexin A2 plays an important role in
exocytosis in chromaffin cells [66], where its function is
mediated by cholesterol- and sphingomyelin-rich lipid
microdomains (lipid rafts): annexin A2 influenced exocy-
tosis via formation or stabilization of lipid rafts, and
reduction of annexin A2 reduced exocytosis at the stage
before membrane fusion [67]. The annexin A2-S100A10
complex is involved in the formation of E-cadherin-based
adherens junctions, in a cholesterol-dependent manner
[68]. However, biochemical data indicate that annexin A2
does not bind cholesterol directly, and these effects are
strictly dependent on the presence of PS in liposomes [69].
Cholesterol in liposomes is able to increase Ca2?-depen-
dent binding of NH2-terminally truncated annexins,
showing that the NH2-terminus is not involved. Cholesterol
increases the Ca2? sensitivity of membrane binding
of annexins A2 and A6, possibly by clustering/stabilizing
PS-rich domains.
Similarly, annexins A5 and A6 show a cholesterol-med-
iated enhancement of their Ca2?-dependent binding to
membranes, indicating that the annexin core domain is
responsible for the cholesterol-mediated effects [70].
Annexin A6 is involved in the endocytosis of low-density
lipoprotein (LDL) by regulating the entry of ligands into the
pre-lysosomal compartment [71]. Cholesterol was shown to
influence the membrane-binding affinity and intracellular
distribution of annexin A6, and changes in its intracellular
distribution and concentration in different subcellular
compartments caused the reorganization of intracellu-
lar pools of annexin A6 [72]. Annexin A6 plays an important
role in the transport of both cholesterol and caveolin. Cells
expressing high levels of annexin A6 are characterized by an
accumulation of caveolin-1 in the Golgi complex [73]. This
was associated with a sequestration of cholesterol in the late
endosomes and lower levels of cholesterol in the Golgi and
the plasma membrane, both likely contributing to retention
of caveolin in the Golgi apparatus and reduced number of
caveolae at the cell surface. The elevated expression levels
of annexin A6 perturb the intracellular distribution of cho-
lesterol, indirectly inhibiting the exit of caveolin from the
Golgi complex.
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Annexins and membrane rafts
Compartmentalization of the plasma membrane has been
shown to be a prerequisite for the efficient and precise
processing of signals across the plasma membrane. Lateral
segregation of cholesterol- and sphingomyelin-rich lipid
microdomains (rafts) and glycerophospholipid-containing
non-raft regions has been proposed to play a role in a
variety of biological processes [74–76]. The early studies
indicated a Ca2?-dependent association of certain annexins
with lipid rafts [77, 78]. In mammary epithelial cells,
CD44, the major cell surface receptor for hyaluronic acid,
was shown to localize to detergent-resistant cholesterol-
rich raft microdomains that contain annexin A2 at their
cytoplasmic face. These CD44-containing lipid microdo-
mains also interact with the underlying actin cytoskeleton
[78]. When examining the structure of smooth-muscle
plasmalemma, we showed that annexins A2 and A6
translocate to the detergent-resistant sites of the smooth-
muscle cell in a Ca2?-dependent manner [8]. We further
extended these observations by showing that the members
of the annexin protein family each associate with different
membrane compartments [79] (Fig. 2). Selective extraction
of cholesterol prevents the relocation of annexin A6, but
not of annexin A4 to the sarcolemma [35]. In contrast, the
extraction of glycerophospholipids results in solubilization
of annexins A1 and A4 whereas annexins A2 and A6
remain associated with the detergent-resistant membranes
[35].
Upon binding, some members of the family have been
shown to induce segregation of membrane lipids, with
certain phospholipids accumulating underneath the sites
of annexin attachment [80]. By means of scanning force
and fluorescence microscopy of artificial membranes
immobilized on mica surfaces, the lateral organization of
the annexin A2-S100A10 heterotetramer and its influence
on the lateral organization of the lipids within the membrane
have been elucidated. A depletion of the 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoserine domains was observed
in the vicinity of annexin A2 tetramer protein domains,
indicating that it was a peripheral membrane-binding
complex capable of inducing lipid segregation [81]. Addi-
tionally, in the presence of Ca2?, annexin A2 caused the
association of rafts [8]. It is therefore possible that
the annexins might constitute a means of regulating
Ca2?-dependent raft-assemblage [8]. In smooth-muscle
cells, the raft binding of annexin A2 could be interrupted
following the proteolytic cleavage of the annexin [82]. This
cleavage is initiated by calpain and is dependent on [Ca2?]i
and the presence of an intact contractile apparatus. Proteol-
ysis abolishes annexin-binding to the plasma membrane and
might result in the rearrangement of membrane constituents
followed by the interruption of segregation-dependent sig-
naling events [85].
The important function of annexins in raft organization
was further strengthened by our experimental data showing
that the structural changes in plasma membrane of con-
tractile cells during development were accompanied by
alterations of expression and localization of specific
annexins [83]. The differences in skeletal and smooth-
muscle sarcolemma can already be observed at the
microdomain level and are characterized by a relative
paucity of lipid rafts in differentiated skeletal muscle.
However, the undifferentiated skeletal myoblasts and
myotubes closely resemble smooth-muscle cells in their
expression of raft-associated lipids and proteins. During
differentiation in the early perinatal period, the plasma
membrane of skeletal muscle undergoes a striking reorga-
nization of its lipid and protein components; we showed
that 50-nucleotidase activity markedly decreased, concom-
itantly with transverse tubular invagination and terminal
maturation of the skeletal-muscle sarcolemma. Simulta-
neously, membrane microdomain segregation became less
apparent and raft-associated annexins A2 and A6 were
downregulated. Annexin intracellular localization was also
changing; the annexins were diffusely distributed within
myotubes, transiently co-localized with caveolin-3 during
embryogenesis, and expressed in the T-tubules within
mature myocytes.
During monolayer culturing, smooth-muscle and endo-
thelial cells are known to undergo dramatic cytoskeletal
and plasma-membrane rearrangements. This extensive
reorganization of the plasma membrane coincides with
changes in the expression levels of the lipid raft marker
proteins annexins A2, A6, and 50-nucleotidase [84]. These
three raft markers were massively upregulated in
monolayer cultures of endothelial or smooth-muscle cells
Fig. 2 Annexins interact with different lipid microdomains. Interde-
pendent but not identical gradients of individual lipids exist within the
membrane bilayer. The lipid moieties are responsible for targeting
annexins to their respective places within the membrane. The
segregation is further stabilized via an interaction of the membrane
with the submembraneous cytoskeleton
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(single or co-cultures) compared with the levels in native
smooth-muscle tissue or three-dimensional spheroids.
Similarly, in the smooth-muscle cultures, the transition
from normal spindle-shaped to epithelioid morphology is
accompanied by structural changes in sarcolemma: the
epithelioid cells had 30% higher levels of cholesterol and
correspondingly lower levels of glycerophospholipids [85].
These changes in sarcolemmal lipid composition were
associated with a reduced diversity in the range of mem-
brane-binding annexins: expression of annexins A1, A4,
A6, and A7 was lost, whereas the levels of annexins A2
and A5 were increased. Interestingly, in epithelioid cells,
cholesterol was more susceptible to extraction, implicating
loss of annexins and altered intracellular distribution of
caveolin in membrane stabilization.
Annexin A1 interacts with ceramide platforms
The ability of annexins to sense Ca2? signals and specific
lipid second messengers is further elucidated in our recent
study, which demonstrates the involvement of annexin A1
in the Ca2?-dependent production of ceramide and its
clustering into platforms at the plasma membrane of living
cells [86]. Ceramide is a key lipid mediator in cellular
processes such as differentiation, proliferation, growth
arrest, and apoptosis [87, 88]. Ceramide is synthesized
de novo in the ER and transported to the Golgi apparatus
where it is converted into complex sphingolipids. Alter-
natively, intracellular sphingomyelinases, triggered by a
variety of pro-apoptotic signals, can convert sphingomyelin
to ceramide at the plasma membrane [89]. Upon its genesis
during apoptosis, ceramide self-associates into platforms,
thereby promoting extensive structural changes within the
plasma membrane [90, 91]. Hence, its classical role as a
second messenger is being challenged in favor of a more
general one, involving gross reorganization of membrane
structure, clustering of signaling molecules, and an
amplification of vesicle formation, fusion, and trafficking.
We showed that ceramide increased the affinity of
annexin A1-membrane interaction [86]. In the physiologi-
cally relevant range of Ca2? concentrations, this leads to an
increase in the Ca2?-sensitivity of annexin A1-membrane
interaction. Among proteins of the annexin family, the
interaction with ceramide platforms is restricted to annexin
A1 and is conveyed by its unique NH2-terminal domain
(Fig. 3). Using fluorescently tagged annexin A1 as a
reporter for ceramide platforms and annexin A6 as a non-
selective membrane marker, we visualized ceramide
platforms and provided evidence for a ceramide-driven
segregation and internalization of membrane-associated
proteins (Fig. 4).
Among other functions, annexin A1 is believed to act as
a mediator of anti-inflammatory glucocorticoids [92].
Annexin A1-/- cell lines overexpress Cox-2 and cPLA2
and are insensitive to dexamethasone, implicating annexin
A1 in the inhibition of inflammatory and proliferative
signal transduction pathways [93]. Additionally, this pro-
tein plays a role in the execution of apoptosis [94] and the
clearance of apoptotic cells by macrophages [95]. An
interaction between annexin A1 and ceramide platforms
occurs under conditions of cellular stress. Annexin A1 can
influence the dynamic of lipid condensed domains in
phospholipid monolayers [96]. This suggests that, in living
cells, the formation of ceramide platforms might be pro-
moted by annexin A1 binding. Annexin A1 has been shown
to be released by apoptotic cells [95]. Our results indicate
that the formation of ceramide platforms within the outer
lipid bilayer together with the exposure of phosphatidyl-
serine might serve as a stimulus for annexin A1 binding to
apoptotic cells and mediate an annexin A1-dependent
clearance of apoptotic cells by macrophages and annexin
A1-induced apoptosis of surrounding cells [94].
Membrane curvature is sensed by annexin B12
Changes in membrane curvature take place during many
cellular processes, including movement, division, and
vesicular trafficking. Curvature can be dynamically mod-
ulated by changes in lipid composition, the oligomerization
Fig. 3 The interaction between annexin A1 and ceramide platforms.
Under conditions of stress, accompanied by sustained elevation of
[Ca2?]i, acid sphingomyelinase (aSMase) converts sphingomyelin
(SM) to ceramide (Cer) (red arrow). The green arrow indicates the
spontaneous transbilayer equilibration of ceramide in the plasma
membrane (PM) between the extra- and intracellular compartments
(out, in). The Ca2?-mediated interaction between the annexin core
and anionic phospholipids induces conformational changes in the
annexin A1 molecule that result in the previously buried NH2-termi-
nal domain becoming externally accessible. The unique
NH2-terminus of annexin A1 conveys the selective interaction of
the protein with the phase boundaries and its penetration into the
highly ordered domains of tightly packed acyl chains formed in the
membrane upon generation and self-association of ceramide.
Anx1 Annexin A1, core annexin A1 core domain, N-ter unique
NH2-terminal domain of annexin A1
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of curvature scaffolding proteins, and the reversible
insertion of protein regions that act like wedges in mem-
branes. There is an interplay between curvature-generating
and curvature-sensing proteins during vesicle budding [97].
For example, the Golgi-associated protein ArfGAP1 has an
unusual membrane-adsorbing amphipathic alpha-helix: its
polar face is weakly charged, containing mainly serine and
threonine residues, and it was shown that this feature
explained the specificity of ArfGAP1 for curved versus flat
lipid membranes [98].
In a recent study by Fischer et al. [99], a combination of
biochemical and biophysical approaches was used to ana-
lyze the interaction of annexin B12 with membranes of
different curvatures. The authors observed a selective and
Ca2?-independent binding of annexin B12 to negatively
charged vesicles that were either highly curved or con-
tained lipids with a negative intrinsic curvature. This novel
curvature-dependent membrane interaction induced major
structural rearrangements in the annexin protein and
resulted in a backbone fold that was different from that of
the well characterized Ca2?-dependent membrane-bound
form of annexin B12. Following curvature-dependent
membrane interaction, the protein retained a predominantly
alpha-helical structure but underwent inside-out refolding
that brought previously buried hydrophobic residues into
contact with the membrane. These structural changes were
Fig. 4 Binding of annexin A1
to ceramide platforms under
conditions of cellular stress. The
formation of annexin
A1-positive ceramide platforms
was monitored in live Jurkat
T-cells co-transfected with
annexin A1-YFP (Anx1: yellow)
and annexin A6-CFP (Anx6:
blue). The cells were
maintained in Tyrode’s buffer
containing 2 mM CaCl2 and
challenged with Ca2?/
ionomycin at 30 s. Data sets
were obtained with a ZEISS
LSM 510 Meta at the time
points indicated. Sustained
elevation of [Ca2?]i results in
the formation of ceramide,
which accumulates within
plasma membrane platforms
(arrows). Annexin A1, but not
annexin A6, associates with
ceramide platforms
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reminiscent of those previously observed following a
Ca2?-independent interaction of annexins with membranes
at mildly acidic pH (see below), yet they occurred at
neutral pH in the presence of curved membranes. There-
fore, annexin B12 could be a sensor of membrane
curvature, thus explaining the previously reported
Ca2?-independent membrane interaction of annexins in
vivo occurring at neutral pH.
Many signaling proteins are modulated by changes in
lipid composition and concomitant alterations of the cur-
vature. The activity of membrane-associated PKC was
shown to be tightly controlled by the physical properties of
the membrane lipid bilayer, in particular, curvature stress,
which is induced by bilayer-destabilizing lipid components
[100, 101]. It is therefore possible that the ability of
annexins to sense lipid-induced changes in membrane
curvature could bring them into contact with other signal-
ing molecules at the plasma membrane, i.e. PKC, and thus
allow them to modulate different signaling pathways both
Ca2?-dependently and Ca2?-independently.
Annexins and the cytoskeleton
The cortical cytoskeleton has an important function in sta-
bilizing the plasma membrane and is involved in the
regulation of multiple cellular processes under normal
conditions and during stress. Several members of the
annexin family are capable of binding to actin [102].
Annexin A2 binds F-actin [103], and its knock-down
decreases the migration of human glioma cells [104].
Annexin A2 is essential for actin-dependent vesicle trans-
port, as discussed above [59, 105]. In spontaneously motile
cells, Hayes et al. [106] demonstrated that annexin A2 was
observed in dynamic actin-rich protrusions, and its depletion
led to the accumulation of stress fibers and loss of protrusive
and retractile activity. Annexin A2 reduced the polymeri-
zation rate of actin monomers in a dose-dependent manner
by inhibiting the filament elongation at the barbed ends.
These results point to the essential role of annexin A2 in the
plasticity of a dynamic, membrane-associated actin cyto-
skeleton, achieved through direct interactions with
polymerized and monomeric actin [106]. In polarized epi-
thelial cells, annexin A2 in complex with S100A10 and
AHNAK protein recruit the cortical actin cytoskeleton and
have been implicated in the regulation of the actin cyto-
skeleton organization at the lateral plasma membrane [107].
Recently, it has been shown that leukemia-cell-associ-
ated annexin A8 binds Ca2?-dependently and with high
specificity to PtdIns4,5P2, interacts with F-actin, and asso-
ciates with late endosomes [108, 109]. Interestingly, these
properties of annexin A8 closely resemble annexin A2,
which could be an indication of the functional redundancy
within the annexin protein family.
The role of annexin A6 in endocytosis has been linked to
cytoskeletal modification [110]. It is required for the bud-
ding of clathrin-coated pits from human fibroblast plasma
membranes: annexin A6 binds to b-spectrin at the cell
surface, consequently recruiting and activating a calpain-
like protease. This seems to open the actin cytoskeleton to
facilitate the initial steps of endocytosis. In smooth-muscle
cells, annexin A6 together with annexin A2 forms a Ca2?-
dependent, plasmalemmal complex with actin filaments
[111]. These annexins can also associate with F-actin-
containing stress fibers in cultured smooth-muscle cells or
fibroblasts in a Ca2?-independent manner [112]. A com-
plex of annexin A6 with actin has been suggested to
stabilize the cardiomyocyte sarcolemma during cell stim-
ulation [113].
In activated platelets, in high [Ca2?], annexin A5 was
shown to associate with the cortical cytoskeleton by
forming a specific bond to c-actin [114]. Similarly, annexin
A1 has been identified as a Ca2?- and F-actin-binding
protein in fractionated brain cortex [115]. In addition,
annexin A1 interacts with profilin [116]. The interaction
between annexin A1 and profilin was implicated in the
regulation of the dynamic membrane-cytoskeleton organi-
zation, based on the submembrane localization of annexin
A1 and the regulatory activity of profilin on the cytoskel-
eton [117]. During the onset of diabetes, the endothelial
plasma membrane proteins actin, annexin A1, annexin A2,
the p34 subunit of the Arp2/3 complex, and the Ras sup-
pressor protein-1 become glycated [118]. The authors
suggest that the nonenzymatic glycosylation of the cortical
cytoskeleton-associated proteins has possible consequences
for the fluidity of the endothelial plasma membrane and
impairment of the endothelial mechanotransducing ability
during hyperglycemia.
Annexins require different [Ca2?]i for membrane
interaction
Earlier studies using synthetic lipid vesicles [53, 54],
chromaffin granules [26], and neutrophil secretory vesicles
[119] demonstrated that annexins have diverse Ca2? sen-
sitivities of lipid binding. The individual [Ca2?] required
for this association differ greatly, depending on the
experimental setup and the source of the protein, which
complicates a comparison of the data. In addition, the lipid
composition of the bilayer is known to influence the
affinity of annexins to the synthetic membranes [120].
Smooth-muscle-cell contraction is regulated by changes
in [Ca2?]i. The smooth muscle expresses a broad array of
annexins [111]. Using biochemical methods, we showed
that each annexin required a subtly different individual
level of free calcium for its translocation to the plasma
membrane [35]: around 300 nM for annexin A2, 700 nM
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for annexin A6, 1 lM for annexin A4, and 1.5 lM for
annexin A1. Similarly, when examining the Ca2?-induced
translocations of four members of the annexin family and
of two truncated annexins in live cells, we demonstrated
that these proteins interact with the plasma membrane as
well as with internal membrane systems in a highly coor-
dinated manner [121]. In cells stimulated with ATP or
carbachol, annexin A2 briefly associates with the plasma
membrane during the transient elevation in [Ca2?]i corre-
sponding to a Ca2? release from intracellular stores
(Fig. 5a). Simultaneous Ca2? imaging in transfected cells
showed that the timing and duration of this association
exactly corresponds to the [Ca2?]i elevation. Annexin A6
translocated to the plasma membrane only when a sus-
tained Ca2? influx was induced by activation of store-
operated channels with thapsigargin (Fig. 5b). A similar
behavior has been observed for PKCa in differentiated
PC12 cells following stimulation of ionotropic P2X
receptors [122]. Hence, apart from the amplitude, the
duration and/or the site of the influx (close to the plasma
membrane) influenced the translocation of annexin A6.
Annexin A2 is the most Ca2?-sensitive of the studied
proteins, followed by annexin A6, annexin A4, and annexin
A1 (Fig. 5c). The calcium sensitivity of annexin A2
increases further following association with S100A10
[121]. Upon elevation of [Ca2?]i, annexins A2 and A6
translocate to the plasma membrane, whereas annexins A4
and A1 also become associated with intracellular mem-
branes and the nuclear envelope. The NH2-terminus has a
modulatory effect on plasma membrane binding: its trun-
cation increases the Ca2? sensitivity of annexin A1 and
decreases that of annexin A2 [121].
A study carried out using fluorescent protein-tagged
annexins in neuroblastoma cells resulted in essentially the
same order of Ca2? sensitivity [123]. The FRET experi-
ments revealed that most annexins were likely to occupy
particular membrane regions, with very little lateral
mobility. Given the fact that several annexins are present
within any one cell, it is likely that they form a sophisti-
cated [Ca2?] sensing system, with a regulatory influence on
other signaling pathways.
pH-dependent membrane interaction and channel
activity of annexins
Apart from the typical Ca2?-dependent membrane binding
described above, annexins have the ability to associate with
both synthetic and natural membranes in the absence of
Ca2? [124–126], which points to the existence of
pH-dependent binding mechanisms, most likely mediated
by hydrophobic interactions. Isas et al. [127] reported that
Fig. 5 Annexins discriminate between the magnitude and duration of
Ca2? signals. Different Ca2? sensitivities of annexins allow them to
interact with the plasma membrane under specific conditions.
a Ca2? transients caused by IP3-mediated release from intracellular
stores (ER) are sensed by the annexin A2-S100A10 complex, which
translocates to the plasma membrane. b Store-operated Ca2? entry
activated by an empty ER results in the plasma membrane translo-
cation of annexin A6 and annexin A2. c Prolonged elevation of
[Ca2?]i, occurring during stress and membrane damage, causes PM
association of annexin A1, which preferentially binds to ceramide-
rich areas
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human annexin A5 and hydra annexin B12 were able to
bind phospholipid vesicles in vitro at pH 5.3 and 5.8,
respectively. Similar interactions were described in further
studies of annexins B12 [125, 128] and human annexin A6
[124, 129]. It should be noted that these studies were
performed in vitro at pH between 4 and 6, i.e., under
conditions that rarely occur in living cells.
We characterized in vivo the influence of intracellular
pH on [Ca2?]i and membrane association of human
annexins A1, A2, A4, A5, and A6 tagged with fluorescent
proteins [130]. Annexin A6 and the heterotetramer A2-
S100A10 (p11)—but not annexins A1, A4, and A5—Ca2?-
independently interact with the plasma membrane at pH
6.6 and 6.8. The dimerisation of annexin A2 within the
annexin A2-S100A10 complex is essential for the
pH-dependent membrane interaction at this pH range. The
observations that annexin A6 interacts with membranes of
late endosomes [71] and annexin A5 induces pH-dependent
vesicle aggregation and fusion [131] point to the fact that
the local acidic microenvironment of certain intracellular
compartments allows such Ca2?-independent membrane
interactions to occur in vivo.
Two types of pH-induced membrane interactions have
been proposed: protein insertion into the membrane
bilayer, resulting in a transmembrane annexin, and the
membrane binding associated with increased hydropho-
bicity of annexins at acidic pH. Exposure to low pH may
cause a significant conformational change in the core
domain generating a transmembrane form of the protein as
suggested for annexins B12 [125, 132], A5 [127], and A6
[124, 133]. In contrast, no such dramatic rearrangement
takes place in the case of annexins A1 and A2 [134]. Under
mildly acidic conditions, annexin A2 binds to and aggre-
gates membranes containing anionic phospholipids. Using
time-resolved fluorescence analysis and the measurement
of Stokes radius, Lambert et al. [134] demonstrated that at
mildly acidic pH, the protein undergoes conformational
changes similar to those induced by Ca2?. These changes
allow access to the hydrophobic part of the membrane at
both acidic pH in the absence of Ca2? and at neutral pH in the
presence of Ca2?. However, membrane bridging by the
annexin A2-S100A10 heterotetramer did not involve further
structural modification of the protein core. The NH2-termi-
nal domain of annexin A2 was implicated in mediating pH-
induced membrane aggregation in vitro [135].
The issue of annexins acting as ion channels in their own
right is somewhat controversial as such activity was only
observed in vitro and usually requires low (below 6.0) pH,
which induces extensive alterations of the protein structure.
Most annexins might be capable of forming membrane
channels in vitro; first described for annexin A7 [136], this
feature was observed also for annexins A5 [136], A2 [137],
and A1 [138]. The crystallographic studies show a
hydrophilic pore at the centre of the annexin molecule,
forming a prominent ion channel coated with charged and
highly conserved residues [139]. The cation/anion perme-
ability ratios of the ion channels formed by several
annexins confirm the selectivity of the annexin channels for
Ca2? over other divalent cations and reveal the importance
of amino acid positions 17, 78, 95, and 112 for the iden-
tification of the ion channel’s position, function, and
regulation. However, the annexin-mediated ion conduc-
tance is reversely proportional to the concentration of
Ca2?, and most annexins require high Ca2? for membrane
interaction. On the other hand, low pH favors membrane
insertion of annexins (see above) and might therefore
promote channel activity. Indeed, the mechanism of pore
formation at low pH was proposed by Langen et al. [140]
based on the membrane-inserted form of annexin B12 at
low pH. Upon pH-induced membrane insertion, a contin-
uous transmembrane alpha-helix is reversibly formed from
a helix-loop-helix motif seen in the solution structure. The
authors identified other regions with similar membrane-
insertion potential in the amino acid sequence and pro-
posed that the corresponding helices come together to form
an aqueous pore mediating the ion channel activity repor-
ted for several annexins [140].
Cell signaling and annexins
Role of annexins in the regulation of intracellular Ca2?
homeostasis and modulation of ion channels
Annexin A6 is the most extensively investigated member
of the family in terms of its influence on intracellular Ca2?
homeostasis and has been implicated in the regulation of
the sarcoplasmic reticulum ryanodine-sensitive Ca2?
channel [141], the neuronal K? and Ca2? channels [142],
and the cardiac Na?/Ca2? exchanger [143]. Studies with
transgenic animals delineated an important function of
annexin A6 in maintaining intracellular Ca2? homeostasis.
Cardiac-specific over-expression of annexin A6 resulted in
lower basal [Ca2?], a depression of [Ca2?]i transients, and
impaired cardiomyocyte contractility [144]. In contrast, the
cardiomyocytes from annexin A6 null-mutants showed
increased contractility and accelerated Ca2? clearance
[145]. Consistent with its role in mediating intracellular
Ca2? signals, especially Ca2? influx, ectopic overexpres-
sion of annexin A6 in A431 cells, which lack endogenous
annexin, resulted in inhibition of EGF-dependent Ca2?
entry [146].
Store-operated Ca2? entry (SOCE) has been proposed as
a main process controlling Ca2? entry in non-excitable cells
[147], and the recent discovery of Orai1 and STIM provided
a missing link between the Ca2?-release-activated current
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(ICRAC) and the ER Ca
2? sensor [148–150]. The actin
cytoskeleton plays a major role in the regulation of SOCE,
possibly by influencing the function of ion channels or by
interfering with the interaction between STIM and Orai1
[151–153]. However, the proteins connecting the actin
cytoskeleton and SOCE activity have yet to be identified.
We targeted annexin A6 to the plasma membrane inde-
pendent of Ca2? and demonstrated that the constitutive PM
localization of annexin A6 resulted in down-regulation of
store-operated Ca2? entry (Monastyrskaya et al., unpub-
lished data). Expression of membrane-anchored annexin A6
caused an accumulation of cortical F-actin, and cytoskeletal
destabilization with latrunculin A abolished the inhibitory
effect of plasma membrane-anchored annexin A6 on SOCE.
Our results implicate annexin A6 in the maintenance of
intracellular Ca2? homeostasis via actin-dependent regula-
tion of Ca2? entry.
The role of annexins as regulators of ion channel
activity has been addressed in a number of studies
(reviewed in [154]). In epithelial cells, annexin A4 had an
inhibitory effect on Ca2?-dependent Cl- conductance
[155]. Using a specific peptide, corresponding to the
NH2-terminus of annexin A2 and interfering with annexin
A2-S100A10 complex formation, it was demonstrated that
this annexin heterotetramer could be involved in the
function of a volume-activated chloride channel in endo-
thelial cells [156].
Recently, several studies implicated annexins in com-
plex with S100 proteins in the regulation of trafficking and
function of several ion channels. Transient receptor
potential channels TRPV5 and TRPV6 have an important
function in Ca2? uptake by kidney and intestine epithelia
[157]. These channels are constitutively active at low
intracellular Ca2? and physiological membrane potential
and have a high selectivity for Ca2?. They are regulated by
associated proteins, including calmodulin, 80K-H, Rab11a,
Na?/H? exchanger regulatory factor 2, and the annexin
A2-S100A10 complex [158]. S100A10 has been identified
as an auxiliary protein for these Ca2? channels using a
yeast two-hybrid system [159]. It was shown that annexin
A2 heterotetramer was co-expressed with TRPV5 and
TRPV6 in Ca2?-transporting epithelia and was essential for
their function. Mutation of a sequence mediating the
interaction of TRPV5 and TRPV6 with S100A10 caused a
major disturbance in the intracellular localization of these
channels, indicating that their complex with A2-S100A10
was mediating their correct trafficking. A similar complex
was detected in airway epithelia [160], and its formation is
regulated by the cAMP/PKA/calcineurin A pathway, which
determines the association between annexin A2 and
S100A10. The same signaling pathway promotes the
interaction of the annexin A2-S100A10 complex with the
cystic fibrosis conductance regulator protein (CFTR) and
regulates its channel function [161, 162]. An acetylated
peptide, corresponding to the NH2-terminus of annexin A2,
harboring the S100A10 interaction site, was shown to
interfere with A2-S100A10/CFTR complex formation,
inhibiting the CFTR current in epithelia.
Similarly, the TWIK-related acid-sensitive K? channel
(TASK1) was shown to be associated with S100A10 via its
C-terminal amino acids [163]. This sequence (SSV)
resembles the binding motif of TRPV channels, suggesting
that both proteins share the binding pocket on S100A10.
This feature, however, is not essential for the interaction, as
the voltage-gated Na? channel (Nav1.8) binds S100A10 via
an unrelated NH2-terminus [164]. A dorsal root ganglion-
specific knock-out of S100A10 allowed examination of its
role in nociception [165]. The expression levels of annexin
A2 were not affected, however, the S100A10-null neurons
showed deficits in the expression of Nav1.8 and attenuation
of acute pain behavior. The annexin A2-S100A10 complex
with the acid-sensing ASIC1 channel was detected by
immunoprecipitation in dorsal root ganglion neurons [166].
Taken together, these findings indicate that the S100A10-
annexin A2 complex plays an important role in the traf-
ficking of several ion channels to the plasma membrane.
The regulation of this complex by cAMP/PKA/calcineurin
adds another important level of control of channel activity
and allows the convergence of different intracellular
pathways on the plasma membrane to be influenced by
annexins.
Regulation of PKC
Similar to the annexins, PKCa is a phospholipid-binding
protein that translocates from the cytoplasm to the plasma
membrane upon elevation of [Ca2?]i [167, 168]. DAG is a
major activator of PKC. Addition of DAG to lipid mem-
branes has been shown to increase Ca2?-binding of several
annexins, in particular annexin A6 (E. Babiychuk, unpub-
lished data). It is therefore possible that both proteins
associate with similar areas of the plasma membrane upon
intracellular stimulation and elevation of [Ca2?]i. Indeed,
activated PKCa was shown to associate with annexin A6 in
skeletal muscle [169]. Unlike annexins A1, A2, and A4,
annexin A6 is not phosphorylated by PKCa and might reg-
ulate Ca2?-dependent PKC activity, either by targeting the
PKC to specific intracellular locations or by competitive
inhibition thus enhancing signal termination [169]. Upon
activation, PKCa has been shown to translocate preferen-
tially to lipid rafts [170, 171], and a Ca2?-dependent
association of PKCa with neurocalcin and annexin A6 has
been observed in lipid rafts from the synaptic plasma
membrane of rat brain [172]. These findings support the
hypothesis that annexin A6 might act as a scaffold for PKC,
thus influencing its function.
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Annexin A5 has been described as a regulator of PKC
activity [173]. In Jurkat cells, annexin A5 inhibited phos-
phorylation of annexin A2 by endogenous PKC and
phosphorylation of myelin basic protein by PKCa [173].
PKC inhibition by annexin A5 was the consequence of
phospholipid sequestration, and the Ca2?-binding site
located in domain 1 of annexin A5 was shown to play a
predominant role in this process. The studies in cell-free
systems demonstrated the ability of annexin A5 to inhibit
the PKC-catalyzed phosphorylation in the presence or
absence of its activator 12-o-tetradecanoylphorbol-13-
acetate (TPA) [174, 175]. Overexpression of annexin A5 in
breast cancer MCF-7 cells resulted in an inhibition of
TPA-induced Ras/ERK signaling via inhibition of PKC,
possibly PKCd, but the exact mechanism of its action has
not been elucidated [176].
Recent studies link the function of PKC to the amount of
PtdIns4,5P2 in the plasma membrane [177, 178]. An
increase in the PtdIns4,5P2 concentration prolongs the
presence of PKCa within the plasma membrane when
PC12 cells were stimulated with ATP, independently of the
DAG generated. When the magnitude of PtdIns4,5P2
binding was compared with that of other polyphosphate
phosphatidylinositols, it was seen to be greater in both
PKCb- and PKCc-C2 domains. The concentration of Ca2?
required to bind to membranes was lower in the presence of
PtdIns4,5P2 for all C2 domains, especially for PKCa.
Considering the preferential binding of annexins A2 and
A8 to PtdIns4,5P2 (see above), one might envisage a reg-
ulatory cross-roads in the function of these protein families.
Regulation of Ras
The activation of Ras occurs downstream of many cell
surface receptors, including receptor protein kinases, and
the Ras/Raf/MAPK pathway serves as a link between the
signalling cascades regulating cell growth, differentiation,
and survival. The Ras GTPases are resident at the inner
leaflet of the plasma membrane and function as molecular
switches, shuttling between an inactive Ras-GDP and an
active Ras-GTP [179]. The GTP/GDP exchange rate is
regulated by nucleotide exchange factors (GEFs) and
GTPase activating proteins (GAPs) [180, 181]. Earlier
studies established the existence of a specific interaction
between annexin A6 and p120GAP [182, 183] and showed
that this binding was Ca2?-independent and required amino
acids 325–363 of annexin A6, localized in the inter-lobe
linker region of the protein. Since this binding site does not
interfere with the Ca2?-dependent interaction of annexin
A6 with the plasma membrane, it might facilitate the
membrane binding of p120GAP, and indeed it was shown
that annexin A6 inactivated Ras by recruiting p120GAP to
the plasma membrane [184, 185]. In CHO cells, the
elevation of Ca2? following an activation of growth factor
receptors promoted a membrane association of the annexin
A6-p120GAP complex and consequently a reduction of
EGF-induced activation of Ras and Raf-1.
Overexpression of epidermal growth factor receptor
(EGFR) is associated with enhanced activation of wild-
type (hyperactive) Ras in breast cancer [186]. Recently it
was shown that annexin A6 was down-regulated in a
number of EGFR-overexpressing and estrogen receptor-
negative breast cancer cells [186]. In these cells, the
restored expression of annexin A6 promoted Ca2?- and
EGF-inducible membrane targeting of p120GAP. The
Ca2?- and EGF-inducible complex of annexin A6 with H-
Ras was detected by co-immunoprecipitation from the cell
lysates of these cells, and FRET microscopy confirmed the
close proximity of annexin A6 and the active (G12V), but
not inactive (S17N) H-Ras [186]. Interestingly, the
expression of annexin A6 is reduced or lost in many can-
cers [187], which might have a bearing for cancer
progression. It is likely that the tumor-suppressing activity
of annexin A6 is linked to its ability to cause the down-
regulation of the cell proliferation pathways initiated by
activated Ras.
Annexins and intracellular stress
Membrane interaction upon hypoxia-induced
intracellular acidification
The intracellular pH (pHi) is an important physiological
parameter, and several proteins have the ability to interact
with cellular membranes in a pH-dependent manner, thus
acting as pH sensors: cytochrome C, Bcl-xL, and chro-
mogranins A and B have been shown to bind lipid
vesicles at acidic pH [188–190], and ARF1 is associated
with endosomal membranes in a pH-dependent manner
[191].
Hypoxia and ischemia are associated with a decrease in
pHi: a mean pHi of 5.3 was demonstrated in hippocampal
neurons [192, 193]. Subjecting the cells to hypoxia induced
a robust expression of the oxygen-regulated HIF-1 subunit
HIF-1a, observed already after 1 h of exposure, and a
concomitant decrease in the pHi [130]. We showed that
hypoxia promoted the interaction of recombinant annexin
A2-S100A10 and annexin A6 with the plasma membrane:
exposure to hypoxic conditions resulted in an association
of annexin A6 with the plasma membrane [130]. Similarly,
the annexin A2-S100A10 heterotetramer translocated to
the plasma membrane after 30 min of hypoxia. The pHi
values required for membrane association of the recombi-
nant annexin A2-S100A10 in normal and hypoxic
conditions correlate well, which indicates that it is the
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hypoxia-induced intracellular acidification and not the
reduction of O2 per se that drives the interaction [130].
Intracellular pH values, which in resting cells are in the
neutral range (7.0–7.2), can change rapidly during muscle
contraction: intramuscular pH declines from 7.1 to 6.5 due to
skeletal-muscle fatigue [194]. Hypoxia and ischemia are
accompanied by a dramatic drop in pHi. This decrease
probably results from immediate blockade of oxidative
phosphorylation and activation of glycolysis [195]. An
important consequence of intracellular acidification in
neurons is the Ca2?-dependent increase in neurotransmitter
release [196]. In the heart, an ischemia-induced decrease in
pHi from 7.4 to 6.7 has recently been shown to activate the
acid-sensing ion channels (ASICS) in the sensory neurons
and contribute to the sensation of angina [197]. Interest-
ingly, hypoxia induced the expression of annexins A2 and
A5 in the placental cell line BeWo, whereas the levels of
antioxidants and some cytoskeletal proteins were reduced
[198]. Similarly, hypoxia induced the expression of annexin
A2 in cultured human cervical epithelial cells [199]. The
annexin A2-S100A10 complex, shown to regulate ASICS1
[166] under normal conditions, might therefore have an
additional function during hypoxic stress, thus indirectly
contributing to the regulation of pH-induced ion channel
activity. Alternatively, annexin A6, recruited to the plasma
membrane by a decrease in pHi, might influence the pH
homeostasis through its interaction with PKC, a known
regulator of the activity of the NHE1 proton exchanger.
Cellular stress and membrane repair
Hypoxia, osmotic and heat shock, oxidative stress, and
local membrane damage result in the activation of multiple
intracellular signaling pathways, accompanied by changes
in [Ca2?]i and leading ultimately to adaptive changes in
gene expression. Oxidative stress has been shown to affect
expression and localization of different annexins. In earlier
publications, annexin A2 was identified as an oxidant-
sensitive protein, based on a screen of transient incorpo-
ration of glutathione into cellular proteins [200].
Glutathionylation inhibited the membrane-binding activity
of annexin A2 and might represent a regulatory mechanism
influencing its function at the plasma membrane [201]. In
contrast, annexin A5 was shown to associate Ca2?-inde-
pendently with phospholipid vesicles in vitro at pH 7.4, in
the presence of 3 mM H2O2 [202]. The expression and
localization of annexins was investigated in chronically
hyperoxically stressed endothelial cells [203]. In this study,
annexin expression levels did not change significantly in
response to hyperoxic stress, but immunofluorescence
analysis revealed striking effects on the subcellular local-
ization of certain annexins, including the redistribution of
annexins A5 and A6 from the cytosol to the nucleus.
Annexins have been implicated in the regulation of
repair mechanisms on both tissue and intracellular levels.
Annexin A2 was implicated in wound closure in several
studies. Patchell et al. [204] examined the role of glyco-
sylation and expression of glycoproteins after epithelial
injury and demonstrated that following injury, N-glyco-
sylation events and annexin A2 presentation on the cell
surface of airway epithelial cells are important mediators in
repair [204]. Following mechanical wounding of confluent
monolayers of human airway epithelial cells, glycosylation
staining increased on the cell surface of groups of cells in
the proximity of the wound edge. By membrane protein
biotinylation and immunodetection, the authors have
shown that following mechanical wounding, the presenta-
tion of annexin A2 on the cell surface increased
coordinately with repair. Babbin et al. [205] observed that
gastrointestinal mucosal wound healing is dependent on
actin cytoskeletal reorganization and that there is an
increased expression of annexin A2 in migrating intestinal
epithelial cells. The authors used siRNA-mediated
inhibition of annexin A2 expression and observed Rho
dissociation from membranes and decreased Rho activity
following annexin A2 siRNA transfection. Annexin A2
was observed to co-immunoprecipitate with endogenous
Rho and constitutively active RhoA. These findings sug-
gest that annexin A2 plays a role in targeting Rho to
cellular membranes during epithelial cell migration and
tissue repair [205].
Annexin A1 also has an important function in intracel-
lular repair and tissue regeneration mechanisms. Using
annexin A1-knockout mice, Babbin et al. [206] demon-
strated the role of this annexin in the regulation of
intestinal mucosal injury and repair: annexin A1-deficient
animals exhibited an increased susceptibility to dextran
sulfate sodium-induced colitis with greater clinical mor-
bidity and histopathologically visible mucosal injury [206].
At the intracellular level, both annexins A1 and A2 were
shown to interact with dysferlin in a Ca2?- and membrane-
injury-dependent manner [207]. The distribution of the
annexins and the efficiency of sarcolemmal wound-healing
are significantly disrupted in dysferlin-deficient muscle,
suggesting an important role of annexins in sarcolemmal
repair through mediating membrane fusion.
McNeil et al. [208] established a role of annexin A1 in
membrane repair. They showed that Ca2? entering a cell
through a damaged plasma membrane rapidly triggers
membrane fusion events, resulting in the assembly of a
reparative membrane patch at the defect site. An annexin
A1 function-blocking antibody, a small peptide competitor,
and a dominant-negative annexin A1 mutant protein inca-
pable of Ca2? binding, all inhibited resealing. Coincident
with a resealing event, annexin A1 was observed to con-
centrate at disruption sites. The authors propose that Ca2?
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entry through a disruption locally induces annexin A1
binding to membranes, initiating emergency fusion events
whenever and wherever required.
Annexins as diagnostic tools for human disease
Although there is no direct evidence implicating any
individual member of the annexin family as a disease-
causing gene, in certain clinical conditions, changes in
annexin expression levels or localization may contribute to
the progression of disease. In this way, annexins are indi-
rectly linked to some of the most serious human
pathologies including cardiovascular disease and cancer
[41, 209]. Despite a wealth of experimental data, in the
case of these ‘‘annexinopathies,’’ the translation of scien-
tific results into therapeutic concepts is still in its infancy.
In the meantime, the importance of annexins as diag-
nostic tools is becoming increasingly recognized. Coupled
to thrombolytic enzymes, annexin A5 has localized intra-
vascular thrombi [210]. Technetium-labeled annexin A5
has been used as a marker for apoptotic cells in cardio-
vascular medicine [211], and its specific binding to
phosphatidylserine has made this protein a potential can-
didate for predicting the effectiveness of cancer
chemotherapy [212]. Annexin A1, which has been credited
with anti-inflammatory properties [213], is thought to
contribute to the resolution of an inflammatory response by
the removal of extravasated neutrophils [214]. Therefore
the ability of annexins to respond to disease- and stress-
related alterations of the cellular environment and restore
the intracellular homeostasis makes this protein family an
important group of diagnostic and therapeutic targets.
Conclusions
A chronic stress response triggers the activation of differ-
ent intracellular pathways, resulting in profound changes in
Ca2? and pH homeostasis, production of lipid second
messengers such as PtdIns4,5P2, DAG, and ceramide, and
an alteration of membrane curvature caused by clustering
of specific lipids. These changes are sensed by the mem-
bers of the annexin protein family, which have the ability
to interact with specific lipid moieties at the plasma
membrane and simultaneously associate with various sig-
naling proteins.
Indeed, annexins act as sensors for [Ca2?]i. They
interact with the plasma membrane and other cellular
membranes in a coordinated, Ca2?-dependent manner. The
Ca2? sensitivity of annexin-membrane binding is affected
and modulated by interaction with other proteins and pro-
teolytic cleavage, and several annexins present within any
one cell form a broad-range [Ca2?]i-sensing system.
Additionally, annexins respond to pHi decrease, and spe-
cifically annexins A6 and A2-S100A10 act as pH sensors
by interacting with the plasma membrane of living cells
upon a decrease in pHi to 6.6 and 6.8. The pH-induced
membrane interaction of annexins is Ca2?-independent
and, together with the ability of annexins to sense changes
in membrane curvature, represents an important alternative
mechanism of membrane binding.
Intracellular acidification, oxidative stress, and a con-
comitant increase in [Ca2?]i promote membrane binding of
annexins, which have distinct preferences as to the proteins
and lipids with which they interact. Annexins A1, A2, and
A6 act as sensors for lipid second messengers ceramide,
PtdIns4,5P2 (PIP2), and DAG. Upon membrane binding,
annexins regulate various signaling pathways, including the
activation of PKC and Ras, and regulate Ca2? homeostasis
by affecting ion channels and Ca2? entry. Importantly, they
also affect the mechanism of intracellular membrane repair
in a Ca2?-dependent manner, thus defining cell survival and
proliferation under stress conditions.
The high degree of sequence conservation, and consid-
erable functional and structural redundancy of different
annexins renders them important regulators of cell signaling.
Novel functions of individual members of the annexin pro-
tein family, which have recently been elucidated, show the
diversity of these proteins. On the other hand, these specific
functions might be executed in parallel with a more general
role of annexins as watchdogs of intracellular homeostasis,
contributing to cellular adaptation to stress signals.
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